These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 9707056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
    Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF.
    Am J Gastroenterol; 2001 Aug; 96(8):2407-12. PubMed ID: 11513182
    [Abstract] [Full Text] [Related]

  • 3. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.
    Hadrich I, Vandewalle P, Cheikhrouhou F, Makni F, Krichen MS, Sendid B, Standaert-Vitse A, Ayadi A, Poulain D.
    Scand J Gastroenterol; 2007 Jun; 42(6):717-25. PubMed ID: 17505994
    [Abstract] [Full Text] [Related]

  • 4. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1143-52. PubMed ID: 15569117
    [Abstract] [Full Text] [Related]

  • 5. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
    Schoepfer AM, Flogerzi B, Seibold-Schmid B, Schaffer T, Kun JF, Pittet V, Mueller S, Seibold F.
    Am J Gastroenterol; 2009 Oct 15; 104(10):2508-16. PubMed ID: 19532127
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
    Kim BC, Park S, Han J, Kim JH, Kim TI, Kim WH.
    Dig Liver Dis; 2007 Jul 15; 39(7):610-6. PubMed ID: 17531556
    [Abstract] [Full Text] [Related]

  • 8. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
    Vandewalle-El Khoury P, Colombel JF, Joossens S, Standaert-Vitse A, Collot M, Halfvarson J, Ayadi A, Landers CJ, Vermeire S, Rutgeerts P, Targan SR, Chamaillard M, Mallet JM, Sendid B, Poulain D.
    Am J Gastroenterol; 2008 Apr 15; 103(4):949-57. PubMed ID: 18047546
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.
    Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J.
    Gut; 2000 Jan 15; 46(1):58-63. PubMed ID: 10601056
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Candida albicans colonization and ASCA in familial Crohn's disease.
    Standaert-Vitse A, Sendid B, Joossens M, François N, Vandewalle-El Khoury P, Branche J, Van Kruiningen H, Jouault T, Rutgeerts P, Gower-Rousseau C, Libersa C, Neut C, Broly F, Chamaillard M, Vermeire S, Poulain D, Colombel JF.
    Am J Gastroenterol; 2009 Jul 15; 104(7):1745-53. PubMed ID: 19471251
    [Abstract] [Full Text] [Related]

  • 15. Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.
    Sendid B, Dotan N, Nseir S, Savaux C, Vandewalle P, Standaert A, Zerimech F, Guery BP, Dukler A, Colombel JF, Poulain D.
    Clin Vaccine Immunol; 2008 Dec 15; 15(12):1868-77. PubMed ID: 18971303
    [Abstract] [Full Text] [Related]

  • 16. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
    Cruyssen BV, Peeters H, Hoffman IE, Laukens D, Coucke P, Marichal D, Cuvelier C, Remaut E, Veys EM, Mielants H, De Vos M, De Keyser F.
    Clin Exp Immunol; 2005 May 15; 140(2):354-9. PubMed ID: 15807862
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Interest of serologic markers in inflammatory bowel disease. About 105 cases].
    Fekih M, Ben Hlima S, Zitouni M, Matri S, Boubaker J, Makni S, Azza F.
    Tunis Med; 2007 Oct 15; 85(10):821-8. PubMed ID: 18236802
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
    Preda CM, Diculescu M, Mirea V, Marica C, Vermeire S, Rutgeerts P, Oproiu A.
    Rom J Gastroenterol; 2005 Mar 15; 14(1):23-6. PubMed ID: 15800689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.